Latest news with #XD
Indian Express
20-05-2025
- Sport
- Indian Express
Tanisha Crasto and Dhruv Kapila to work with psychologist to help them break into top tier in mixed doubles badminton
Tanisha Crasto and Dhruv Kapila, mixed doubles partners, are both animated and headstrong individuals who have started winning on the badminton court. Their combined on-court game is suitably vivacious, but temperaments can range from methodical to mercurial, going from 0 to 100 in a matter of moments. The three coaches responsible for raising their performance at Hyderabad – Manu Attri, Tan Kim Her and Pullela Gopichand, understand the mixed doubles dynamic and that Tanisha and Dhruv both need an emotional referee, a both-sides negotiator. Their recent on-boarding by Mumbai-based Reliance Foundation is expected to deliver the solution: a joint psychologist for India's rising XD duo, who will smoothen the edges and help the pairing through firefighting, albeit gently, should disagreements arise. 'A psychologist is very important because sometimes Dhruv and I might not be on the same page. A professional can help both of us understand situations better,' Tanisha, now World No 18, says. A dedicated mental trainer will be assigned to the two, in coming days, besides them gaining access to physios and trainers. Dhruv, is a super-driven Ludhiana shuttler, a hard hitter and very prone to allowing aggression to consume his composure. Much like Chirag Shetty, he likes taking on plenty of responsibility and can judge himself harshly in case of mistakes. His back-court game is slowly getting nuanced as Attri and Malaysian coach Tan drill in patience into him, and his flair begins to construct clever points. But the shuttler who moved from up north to Hyderabad in early teens, could do with some pristine Punjabi levity in life, learn to enjoy the battles and delegate pressure to his younger partner. Tanisha, still only 21, is a cannister of uncontainable energy. Equally ambitious, she can be crackling at the net with her fearless aggression and diving around midcourt. She's already an Olympian, she needs to make this combination of fusillade and fiendfyre, work. Fire and ice combinations are known to temper each other's shortcomings. 4 Chinese and 4 Malaysian pairings are ranked above the Indians, besides others. 'It's going to take a lot of time to crack the Top 10,' says Dhruv, 25. 'Mixed doubles is tough. We have to improve everything, skill, techniques, how we handle pressure, and how we train. So the support – of coaches, physios, trainers, psychologists becomes important,' Dhruv says. The pairing enter the Malaysia Masters upbeat after the Sudirman Cup showing, where they were the sole spark in the Indonesia tie. The duo had a good run at German Open in early summer and have been gutsy playing the unbreakable Chinese, though the Top 5 scalps haven't fetched up. Yet. 'In the opening match at Sudirman (where India led with XD) there was lots of pressure, but despite trailing 16-19, we beat Indonesia. We went with the flow, and we have both been trying to sort out (intensity-related nerves) because it's crucial in last stages,' Dhruv says. What works is the immense respect Dhruv has for Tanisha. 'She's great on court, no matter what happens, she pushes herself to win every point. Right now, I'll change nothing about her. Maybe she can be more aggressive,' Dhruv says. Fiery game knows raging game. While Tanisha's front-court errors (mostly precision ones) draw cluckings from critics, her coaches and partner reckon she can Hulk out even more like a Goan gush with her screaming aggression, and not merely tiptoe. Still, mixed doubles invariably fragments into 80 percent of back court responsibility for the male player. 'Tanisha needs to be prepared for the 20 percent,' he says. Her energy though is a perfect foil for the brooding back court enforcer. Away from the court, neither will back off easily and given their flaring natures, a common psychologist can be a useful arbiter. Both need to be physically and mentally ready for long rallies which these days easily skim 70-80 shots. 'Actually, we are prepared for long rallies, and our drills are geared towards those prolonged exchanges. Defenses are so good now, that you can't keep hammering down smashes,' Dhruv says. 'Our mentality is similar – both aggressive, so that helps.' Their serving is getting better with every international outing, but the first three strokes – vastly different in men's doubles and mixed doubles – are a challenge for Dhruv. The duo came together in 2023 after their earlier partnerships in mens doubles and mixed were fraying due to fitness issues for partners. Dhruv was persuaded to stay patient, a second priority, as Tanisha surged to qualify for Paris Olympics in women's doubles with Ashwini Ponappa. December of 2024 saw both reorient and prioritise XD and they entered Top 20 earlier this month. 'It's going pretty well but I have to take more initiative as compared to men's doubles,' he says. Like Tanisha shifted from Dubai to Hyderabad at 16, Dhruv too had found his early years while moving from Ludhiana, grappling with a mix of loneliness and excessive self-pressure to show big results. Mixed doubles partnerships around the world are notorious for turning combustible. It will help to have a common psychologist act as a bookmark to keep them on the same page. There's a bunch of entertaining chapters to be written on this duo.
Business Wire
15-05-2025
- Business
- Business Wire
Cinemark Declares Quarterly Cash Dividend of $0.08
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. ('Cinemark') (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, announced today that its Board of Directors has declared a quarterly cash dividend of $0.08 per share of common stock. The dividend will be paid on June 12, 2025 to stockholders of record on May 29, 2025. About Cinemark Holdings, Inc.: Headquartered in Plano, TX, Cinemark (NYSE: CNK) is one of the largest and most influential movie theater companies in the world. Cinemark's circuit, comprised of various brands that also include Century, Tinseltown and Rave, as of March 31, 2025 operated 497 theaters with 5,644 screens in 42 states domestically and 13 countries throughout South and Central America. Cinemark consistently provides an extraordinary guest experience from the initial ticket purchase to the closing credits, including Movie Club, the first U.S. exhibitor-launched subscription program; the highest Luxury Lounger recliner seat penetration among the major players; XD - the No. 1 exhibitor-brand premium large format; and expansive food and beverage options to further enhance the moviegoing experience. For more information go to Forward-looking Statements Certain matters within this press release include 'forward–looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can identify forward-looking statements by the use of words such as 'may,' 'should,' 'could,' 'estimates,' 'predicts,' 'potential,' 'continue,' 'anticipates,' 'believes,' 'plans,' 'expects,' 'future' and 'intends' and similar expressions which are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict. Such risks and uncertainties could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. These forward-looking statements are based on information currently available as well as management's assumptions and beliefs today. For a description of these factors, please review the 'Risk Factors' section or other sections in the Company's Annual Report on Form 10-K filed February 19, 2025 and quarterly reports on Form 10-Q, filed with the Securities and Exchange Commission. All forward-looking statements are expressly qualified in their entirety by such risk factors. Forward-looking statements contained in this press release reflect our view only as of the date of this press release. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Yahoo
02-05-2025
- Business
- Yahoo
Cinemark Holdings, Inc. Reports First Quarter 2025 Earnings Results
PLANO, Texas, May 02, 2025--(BUSINESS WIRE)--Cinemark Holdings, Inc. ("Cinemark") (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today reported results for the three months ended March 31, 2025. Cinemark issued a full detailed presentation of its first quarter results, which can be viewed on Cinemark's Investor Relations website at in the financial results section. Conference Call Cinemark will host a public audio webcast on Friday, May 2, 2025 at 8:30 a.m. Eastern Time. During the webcast, members of Cinemark's senior management team will review Cinemark's financial results for the first quarter. Interested parties can listen to the call via live webcast. Please access 5-10 minutes before the call: A replay of the call will be available at following the call and archived for a limited time. To automatically receive Cinemark financial news by email, please visit our Investor Relations website and subscribe to email alerts. About Cinemark Holdings, Inc. Headquartered in Plano, TX, Cinemark (NYSE: CNK) is one of the largest and most influential movie theater companies in the world. Cinemark's circuit, comprised of various brands that also include Century, Tinseltown and Rave, as of March 31, 2025 operated 497 theaters with 5,644 screens in 42 states domestically and 13 countries throughout South and Central America. Cinemark consistently provides an extraordinary guest experience from the initial ticket purchase to the closing credits, including Movie Club, the first U.S. exhibitor-launched subscription program; the highest Luxury Lounger recliner seat penetration among the major players; XD - the No. 1 exhibitor-brand premium large format; and expansive food and beverage options to further enhance the moviegoing experience. For more information go to View source version on Contacts Investor Contact:Chanda Brashearscbrashears@ Media Contact:Caitlin Piperpr@
Business Wire
02-05-2025
- Business
- Business Wire
Cinemark Holdings, Inc. Reports First Quarter 2025 Earnings Results
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. ('Cinemark') (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today reported results for the three months ended March 31, 2025. Cinemark issued a full detailed presentation of its first quarter results, which can be viewed on Cinemark's Investor Relations website at in the financial results section. Conference Call Cinemark will host a public audio webcast on Friday, May 2, 2025 at 8:30 a.m. Eastern Time. During the webcast, members of Cinemark's senior management team will review Cinemark's financial results for the first quarter. Interested parties can listen to the call via live webcast. Please access 5-10 minutes before the call: A replay of the call will be available at following the call and archived for a limited time. To automatically receive Cinemark financial news by email, please visit our Investor Relations website and subscribe to email alerts. About Cinemark Holdings, Inc. Headquartered in Plano, TX, Cinemark (NYSE: CNK) is one of the largest and most influential movie theater companies in the world. Cinemark's circuit, comprised of various brands that also include Century, Tinseltown and Rave, as of March 31, 2025 operated 497 theaters with 5,644 screens in 42 states domestically and 13 countries throughout South and Central America. Cinemark consistently provides an extraordinary guest experience from the initial ticket purchase to the closing credits, including Movie Club, the first U.S. exhibitor-launched subscription program; the highest Luxury Lounger recliner seat penetration among the major players; XD - the No. 1 exhibitor-brand premium large format; and expansive food and beverage options to further enhance the moviegoing experience. For more information go to
Yahoo
27-03-2025
- Business
- Yahoo
Exploring XD And Two Other High Growth Tech Stocks In Asia
As global markets navigate a landscape of economic uncertainty and mixed signals, with tech stocks in the U.S. recently lagging behind broader indices, investors are increasingly turning their attention to Asia's high-growth tech sector for potential opportunities. In this environment, identifying strong stocks often involves looking at companies that demonstrate resilience and adaptability amid changing economic forecasts and geopolitical risks, as these qualities can be crucial for sustaining growth in dynamic markets like Asia. Name Revenue Growth Earnings Growth Growth Rating Suzhou TFC Optical Communication 34.71% 33.47% ★★★★★★ Fositek 31.39% 36.95% ★★★★★★ Xi'an NovaStar Tech 30.60% 36.56% ★★★★★★ eWeLLLtd 24.65% 25.30% ★★★★★★ Seojin SystemLtd 31.68% 39.34% ★★★★★★ PharmaResearch 20.19% 26.38% ★★★★★★ giftee 21.13% 67.05% ★★★★★★ JNTC 28.84% 104.08% ★★★★★★ Ascentage Pharma Group International 22.93% 59.90% ★★★★★★ Delton Technology (Guangzhou) 20.25% 29.52% ★★★★★★ Click here to see the full list of 506 stocks from our Asian High Growth Tech and AI Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Growth Rating: ★★★★★☆ Overview: XD Inc. is an investment holding company that focuses on developing, publishing, operating, and distributing mobile and web games in Mainland China and internationally with a market cap of approximately HK$18.24 billion. Operations: The company generates revenue primarily through its Game segment, which brought in CN¥2.43 billion, and the TapTap Platform, contributing CN¥1.43 billion. The focus on both game development and the TapTap distribution platform highlights a dual revenue stream strategy within the gaming industry. XD Inc. has demonstrated a robust trajectory with its revenue expected to surge by 46% to 49% year-over-year, reaching up to RMB 5.04 billion in FY 2024. This growth is complemented by an impressive turnaround from a net loss in FY 2023 to a projected net profit of up to RMB 940 million. The company's commitment to innovation is evident from its substantial investment in R&D, fostering advancements that keep it competitive within Asia's tech landscape. Moreover, XD's earnings are poised for a significant annual increase of approximately 54.6%, outpacing the regional market growth and indicating potential for sustained upward momentum in its financial performance. Navigate through the intricacies of XD with our comprehensive health report here. Explore historical data to track XD's performance over time in our Past section. Simply Wall St Growth Rating: ★★★★★★ Overview: Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China, with a market cap of approximately HK$12.61 billion. Operations: The company generates revenue primarily through the development and sale of novel small-scale therapies, amounting to CN¥903.03 million. Ascentage Pharma Group International has shown a notable rebound in its financial performance, with sales soaring to CNY 980.65 million in FY 2024 from CNY 221.98 million the previous year, reflecting a remarkable growth trajectory despite the company's net loss narrowing significantly to CNY 405.43 million from CNY 925.64 million. This improvement is underpinned by strategic R&D investments that fuel innovation across its robust pipeline, highlighted by recent breakthroughs like olverembatinib receiving multiple Breakthrough Therapy Designations in China for critical leukemia treatments. These advancements not only underscore Ascentage's commitment to addressing unmet medical needs but also position it well within the high-stakes biotech sector where it continues to push scientific boundaries at major forums like the AACR Annual Meeting. Dive into the specifics of Ascentage Pharma Group International here with our thorough health report. Examine Ascentage Pharma Group International's past performance report to understand how it has performed in the past. Simply Wall St Growth Rating: ★★★★★☆ Overview: Genew Technologies Co., Ltd. is involved in the global research, development, production, and sale of communication and network products with a market capitalization of CN¥5.73 billion. Operations: Genew Technologies Co., Ltd. focuses on the global research, development, production, and sale of communication and network products. The company operates with a market capitalization of CN¥5.73 billion. Genew Technologies Co., Ltd. has pivoted impressively from a net loss to profitability, showcasing a robust annual revenue growth of 30.6% and an even more striking earnings growth of 71%. This performance outpaces the broader Chinese market's average, indicating strong operational efficiency and market acceptance. The shift to profitability is underscored by a recent earnings report for FY 2024, where sales climbed to CNY 950.22 million from CNY 884.41 million the previous year, and net income reached CNY 27.11 million, reversing the prior year's loss of CNY 86.56 million. This financial turnaround is particularly noteworthy in the context of its R&D commitment—integral to its strategic positioning within Asia's competitive tech landscape—highlighting Genew's potential trajectory in influencing regional tech innovation trends. Unlock comprehensive insights into our analysis of Genew TechnologiesLtd stock in this health report. Evaluate Genew TechnologiesLtd's historical performance by accessing our past performance report. Investigate our full lineup of 506 Asian High Growth Tech and AI Stocks right here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2400 SEHK:6855 and SHSE:688418. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
